Chimeric antigen receptor (CAR)-T cell therapy demonstrates substantial efficacy in various
hematological malignancies. However, its application in solid tumors is still limited. Clinical …

Clustered regularly interspaced short palindromic repeat (CRISPR)-based genome editing
(GED) technologies have unlocked exciting possibilities for understanding genes and …

Artificial Intelligence (AI) has made significant strides in revolutionizing cancer care,
encompassing various aspects from diagnosis to prevention and beyond. With its ability to …

Artificial intelligence (AI) and deep learning have emerged as powerful tools in
understanding the etiology and pathogenesis of cancers. These technologies help uncover …

Simple Summary Pancreatic cancer, with its increasing incidence, is predicted to become
the second deadliest solid tumor by 2040, urging for improved diagnostic and treatment …

This narrative review examines the promising potential of integrating artificial intelligence
(AI) with CRISPR-Cas9 genome editing to advance CAR T-cell therapy. AI algorithms offer …

As an appealing alternative to treat and prevent diseases ranging from cancer to COVID-19,
mRNA has demonstrated significant clinical effects. Nanotechnology facilitates the …

The advent of targeted therapies has led to tremendous improvements in treatment options
and their outcomes in the field of oncology. Yet, many cancers outsmart precision drugs by …

The CRISPR/Cas9 genome editing system is a unique and new technology that allows
genetics and medical researchers to modify or edit parts of the genome. This is achieved by …

Cancer continues to present a substantial global health challenge, with its incidence and
mortality rates persistently reflecting its significant impact. The emergence of precision …